Business, energy, technology, markets and global industry news from Business News Today

bone metastases

PharmaDeviceNews bone metastases
Representative image of bone health biologics research as GlycoNex’s SPD8 Phase III result puts denosumab biosimilar competition, osteoporosis care, and oncology bone disease treatment under sharper focus.
Pharma & Biotech

GlycoNex targets Prolia and Xgeva space as SPD8 meets Phase III equivalence goal

Find out how GlycoNex’s SPD8 Phase III data could intensify denosumab biosimilar competition in osteoporosis and oncology care.

Read More
Representative image: A clinician reviews spinal imaging as Zetagen Therapeutics’ ZetaMet Phase 2a data highlights investigational progress in treating metastatic breast cancer patients with lytic bone lesions.
Pharma & Biotech

Can Zetagen’s ZetaMet Phase 2a data change how metastatic breast cancer bone lesions are treated?

Find out how Zetagen’s ZetaMet Phase 2a data may reshape treatment of metastatic breast cancer bone lesions.

Read More